$6.99
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?
Overview
52-week range
$3.76
$8.95
62% of range
Avg surprise (last 3)
-8.1%
Avg reaction (last 2)
+1.4%
50% positive
Latest IV / EM
78%
EM ±17.9% · $8 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.19 | $-0.24 | +20.8% | +47.2% | -0.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.26 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.52 | $-0.43 | -20.9% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.36 | $-0.29 | -24.1% | — | +3.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.38 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.28 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.27 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | AMC | -$0.22 | -$0.52 | +57.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | — | $5M | $2M | $3M | — | $3M | $2M |
| Cost of revenue | $2M | — | $1M | $593,000 | $768,000 | — | $1M | $812,000 |
| Gross profit | $4M | — | $4M | $2M | $2M | — | $2M | $1M |
| Operating income | $-8M | — | $-9M | $-14M | $-11M | — | $-9M | $-8M |
| Net income | $-7M | — | $-8M | $-16M | $-11M | — | $-9M | $-7M |
| EPS (diluted) | $0.19 | — | $0.26 | $0.52 | $0.36 | — | $0.38 | $0.28 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $50M | $60M | $25M | $35M | $46M | $55M | — | — |
| Inventory | $9M | $8M | $8M | $8M | $7M | $6M | — | — |
| Total current assets | $70M | $76M | $42M | $49M | $60M | $69M | — | — |
| Total assets | $73M | $77M | $42M | $50M | $61M | $70M | — | — |
| Long-term debt | — | $4M | — | $4M | $4M | $3M | — | — |
| Total liabilities | $14M | $11M | $10M | $10M | $10M | $10M | — | — |
| Total equity | $59M | $66M | $32M | $39M | $51M | $60M | $31M | $39M |